Padagis®, a leading generic manufacturer, announced today it is lowering the price of its over-the-counter (OTC) 4 mg ...

The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

Mumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food ...

Public health experts have concerns about the opioid reversal agent Opvee. But the company that makes it, Indivior, has found ...